About Cabazitaxel API
Therapeutic CategoryAnti-Cancer/ Oncology-pt
CAS Number
183133-96-2
API Technology
Synthetic
Dose Form
Injectable
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, EUDMF, Russia DMF
Mechanism of Action
Cabazitaxel is a microtubule inhibitor. Cabazitaxel binds to tubulin and promotes its assembly into microtubules while simultaneously inhibiting disassembly. This leads to the stabilization of microtubules, which results in the inhibition of mitotic and interphase cellular functions.
Indication
JEVTANA is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen.
Related APIs
Enzalutamide-pt
Anti-Cancer/ Oncology-pt
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!